Temps réel
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
14,12 NOK | +2,02% | +6,65% | -34,02% |
Métier
Nombre d'employés: 172
Ventes par activité
NOK en Millions | 2021 | Poids | 2022 | Poids | Delta |
---|---|---|---|---|---|
Novel Vaccines and Immunotherapies
100,0
%
| 292 | 100,0 % | 69 | 100,0 % | -76,39% |
Ventes par région
NOK en Millions | 2021 | Poids | 2022 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 292 | 100,0 % | 69 | 100,0 % | -76,39% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | 47 | 01/01/07 | |
Michael Engsig
CEO | Chief Executive Officer | - | 01/03/07 |
Harald Gurvin
DFI | Director of Finance/CFO | 49 | 03/05/21 |
Chief Tech/Sci/R&D Officer | 50 | 01/06/21 | |
Chief Tech/Sci/R&D Officer | - | 01/08/17 | |
Siri Torhaug
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Mette Husbyn
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/17 |
Mona Welschof
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/13 |
Louise Stubbe
LAW | General Counsel | - | 01/01/22 |
Peter Fatum
PRN | Corporate Officer/Principal | - | 01/01/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | - |
Director/Board Member | 64 | - | |
Director/Board Member | - | - | |
Chairman | 69 | 22/12/21 | |
Director/Board Member | 56 | - | |
Birgitte Volck
BRD | Director/Board Member | 61 | 05/05/21 |
Director/Board Member | 52 | - | |
Anders Tuv
BRD | Director/Board Member | 46 | - |
Elaine Sullivan
BRD | Director/Board Member | 63 | 13/05/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 326 546 444 | 179 598 448 ( 55,00 %) | 0 | 55,00 % |
Coordonnées société
Nykode Therapeutics ASA
Oslo Science Park Gaustadalléen 21
0349, Oslo
+47 22 95 81 93
http://www.nykode.comSecteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-34,02% | 417 M | |
+8,96% | 105 Md | |
-1,43% | 104 Md | |
+5,24% | 22,94 Md | |
-12,15% | 22,34 Md | |
-6,91% | 19,25 Md | |
-39,98% | 17,08 Md | |
-10,04% | 16,96 Md | |
+38,61% | 12,63 Md | |
+313,59% | 8,49 Md |
- Bourse
- Actions
- Action VACC
- Société Nykode Therapeutics